High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine-MedSci.cn

High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

McNamara, LA; Topaz, N; Wang, X; Hariri, S; Fox, L; MacNeil, JR

McNamara, LA (reprint author), CDC, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Atlanta, GA 30333 USA.

AMERICAN JOURNAL OF TRANSPLANTATION, 2017; 17 (9): 2481

科室
- - 订阅+
  - 更多科室
工具
服务